BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12089373)

  • 21. Differential regulation of osteopontin expression in the clipped and nonclipped kidney of two-kidney, one-clip hypertensive rats.
    Gauer S; Hartner A; Hauser IA; Fierlbeck W; Eberhardt W; Geiger H
    Am J Hypertens; 2003 Mar; 16(3):214-22. PubMed ID: 12620700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal (pro)renin receptor upregulation in diabetic rats through enhanced angiotensin AT1 receptor and NADPH oxidase activity.
    Siragy HM; Huang J
    Exp Physiol; 2008 May; 93(5):709-14. PubMed ID: 18192338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin subtype-2 receptors inhibit renin biosynthesis and angiotensin II formation.
    Siragy HM; Xue C; Abadir P; Carey RM
    Hypertension; 2005 Jan; 45(1):133-7. PubMed ID: 15534073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of angiotensin II antagonism on the regression of kidney disease in the rat.
    Remuzzi A; Gagliardini E; Donadoni C; Fassi A; Sangalli F; Lepre MS; Remuzzi G; Benigni A
    Kidney Int; 2002 Sep; 62(3):885-94. PubMed ID: 12164870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 1st communication: antihypertensive effects of valsartan in hypertensive models.
    Yamamoto S; Hayashi N; Kometani M; Nakao K; Inukai T
    Arzneimittelforschung; 1997 May; 47(5):604-12. PubMed ID: 9205773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II.
    Chen K; Mehta JL; Li D; Joseph L; Joseph J
    Circ Res; 2004 Dec; 95(12):1167-73. PubMed ID: 15539634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade.
    Ohlstein EH; Brooks DP; Feuerstein GZ; Ruffolo RR
    Pharmacology; 1997 Nov; 55(5):244-51. PubMed ID: 9399334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of angiotensin II type 2 receptor during regression of cardiac hypertrophy in spontaneously hypertensive rats.
    Der Sarkissian S; Tea BS; Touyz RM; deBlois D; Hale TM
    J Am Soc Hypertens; 2013; 7(2):118-27. PubMed ID: 23414835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.
    Müller DN; Mervaala EM; Dechend R; Fiebeler A; Park JK; Schmidt F; Theuer J; Breu V; Mackman N; Luther T; Schneider W; Gulba D; Ganten D; Haller H; Luft FC
    Am J Pathol; 2000 Jul; 157(1):111-22. PubMed ID: 10880382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 4th communication: improvement of heart failure of rats with myocardial infarction by valasartan.
    Hayashi N; Fujimura Y; Yamamoto S; Kometani M; Nakao K
    Arzneimittelforschung; 1997 May; 47(5):625-9. PubMed ID: 9205776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes.
    Matsushita K; Wu Y; Okamoto Y; Pratt RE; Dzau VJ
    Hypertension; 2006 Dec; 48(6):1095-102. PubMed ID: 17060512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-inflammatory effects of AT1 receptor blockade provide end-organ protection in stroke-prone rats independently from blood pressure fall.
    Sironi L; Gelosa P; Guerrini U; Banfi C; Crippa V; Brioschi M; Gianazza E; Nobili E; Gianella A; de Gasparo M; Tremoli E
    J Pharmacol Exp Ther; 2004 Dec; 311(3):989-95. PubMed ID: 15302895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice.
    Yamamoto E; Kataoka K; Dong YF; Nakamura T; Fukuda M; Tokutomi Y; Matsuba S; Nako H; Nakagata N; Kaneko T; Ogawa H; Kim-Mitsuyama S
    Hypertension; 2009 Sep; 54(3):633-8. PubMed ID: 19597038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Signal transductional mechanism of calpain involved in the regulation of rat hypertrophy myocardium mediated by overloaded pressure].
    Yang YJ; Liu HM; Zhang X; Zhang JH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):599-602, 648. PubMed ID: 17718420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat.
    Hegde LG; Yu C; Renner T; Thibodeaux H; Armstrong SR; Park T; Cheruvu M; Olsufka R; Sandvik ER; Lane CE; Budman J; Hill CM; Klein U; Hegde SS
    J Cardiovasc Pharmacol; 2011 Apr; 57(4):495-504. PubMed ID: 21297495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valsartan inhibited the accumulation of dendritic cells in rat fibrotic renal tissue.
    Wu K; Zhou T; Sun G; Wang W; Zhang Y; Zhang Y; Hao L; Chen N
    Cell Mol Immunol; 2006 Jun; 3(3):213-20. PubMed ID: 16893502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemodynamic effects of valsartan in acute renal ischaemia/reperfusion injury.
    Lopau K; Hefner L; Bender G; Heidbreder E; Wanner C
    Nephrol Dial Transplant; 2001 Aug; 16(8):1592-7. PubMed ID: 11477160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renoprotective mechanisms of angiotensin II antagonism in experimental chronic renal failure.
    Uhlenius N; Miettinen A; Vuolteenaho O; Tikkanen I
    Kidney Blood Press Res; 2002; 25(2):71-9. PubMed ID: 12077487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of renal angiotensin type 1 receptor contributes to the pathogenesis of progressive renal injury in a rat model of chronic cardiorenal syndrome.
    Homma T; Sonoda H; Manabe K; Arai K; Mizuno M; Sada T; Ikeda M
    Am J Physiol Renal Physiol; 2012 Mar; 302(6):F750-61. PubMed ID: 22160776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of valsartan on the expression of angiotensin II receptors in the lung of chronic antigen exposure rats.
    Wang T; Yin KS; Liu KY; Lu GJ; Li YH; Chen JD
    Chin Med J (Engl); 2008 Nov; 121(22):2312-9. PubMed ID: 19080339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.